Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Immuron Limited ( (AU:IMC) ) has shared an announcement.
Immuron Limited has announced the quotation of 877,440 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from July 17, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its stakeholders positively.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of immune-mediated diseases.
Average Trading Volume: 78,544
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.